Congresos

← vista completa

Publicado el 1 de abril de 2008 | http://doi.org/10.5867/medwave.2008.03.901

Búsqueda de biomarcadores y nuevas estrategias terapéuticas en EPOC

Search for biomarkers and new therapeutic strategies in COPD

Bartolomé R. Celli

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Bartolomé R. Celli

St. Elizabeth's Medical Center, Universidad de Tufts,Boston, Estados Unidos

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Celli BR. Search for biomarkers and new therapeutic strategies in COPD. Medwave 2008;8(03):e901 doi: 10.5867/medwave.2008.03.901

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/04/2008

Indice

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, et al. Pulmonary Biomarkers in COPD. Am J Respir Crit Care Med. 2006 Jul 1;174(1):6-14. Epub 2006 Mar 23. | CrossRef | PubMed
  2. Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43. Epub 2006 Jan 19. | CrossRef | PubMed
  3. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med. 2007 Jan 4;356(1):11-20. | CrossRef | PubMed
  4. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, et al. Gene Expression Profiling of Human Lung Tissue from Smokers with Severe Emphysema Am J Respir Cell Mol Biol. 2004 Dec;31(6):601-10. Epub 2004 Sep 16. | PubMed
  5. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax. 2006 Jan;61(1):1-3. | CrossRef | PubMed
  6. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 Feb 1;175(3):250-5. Epub 2006 Oct 19. | CrossRef | PubMed
  7. Mahler DA, Huang S, Tabrizi M, Bell GM. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.. Chest. 2004 Sep;126(3):926-34. | CrossRef | PubMed
  8. Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. Epub 2007 Feb 8. | CrossRef | PubMed
  9. Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, et al. Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD. Chest. 2007 Jan;131(1):37-43. | CrossRef | PubMed
  10. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Oct 15;174(8):867-74. Epub 2006 Jun 23. | CrossRef | PubMed
  11. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006 Dec 21;355(25):2631-9. | CrossRef | PubMed